This page contains the Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee) Roster, which lists the current members and the current number of vacancies for the committee.
Similar Posts
Fresenius Kabi Compounding LLC. Canton, MA. 483 issued 11/05/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/05/2025
Short Title (70 char) Fresenius Kabi Compounding LLC. Canton, MA. 483 issued 11/05/2025
FEI Number 3013438665
Firm Name Fresenius Kabi Compounding LLC
Record Type 483
State MA
Establishment Type OutsoFDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity
The FDA is committed to ensuring data transparency by promoting timely registration and reporting of results information to ClinicalTrials.gov.Educational Resources
Educational ResourcesBaxter Oncology GmbH – 08/27/2024
Baxter Oncology GmbH – 08/27/2024. Country: Germany. Record Type: 483Pharmacy Compounding Advisory Committee Roster
This page contains the PCAC roster, which lists the current members and the current number of vacancies for the committee.E2D(R1) Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports
E2D(R1) Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports